Cassella-med GmbH & Co. KG

1 in Phase 3

Quick facts

Phase 3 pipeline

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

Frequently asked questions about Cassella-med GmbH & Co. KG

What is Cassella-med GmbH & Co. KG's pipeline?

Cassella-med GmbH & Co. KG has 1 drugs in Phase 3, 0 in Phase 2, 0 in Phase 1. Late-stage candidates include St. John's Wort extract.

Related